All Posts: cancer research
-
Supporting St. Baldrick’s with Superheroes, Sumo Wrestling and More
With live music, a silent auction, pie- and donut-eating contests, sumo wrestling, superheroes, speeches, head shaving and more, the 2018 St. Baldrick’s fundraiser, organized by the School of Medicine in support of pediatric cancer research, was more festive than ever.
Category: GUMC Stories
-
Research in a Minute: Giuseppe Giaccone, MD, PhD
As associate director of clinical research at Georgetown Lombardi Comprehensive Cancer Center and professor of medical oncology and pharmacology at Georgetown University School of Medicine, Giuseppe Giaccone, MD, PhD, leads a team of researchers in studying thymic carcinoma, also known as cancer of the thymus.
Category: GUMC Stories
-
Frederick National Laboratory and Georgetown Launch Research and Education Collaboration
A new collaboration between Georgetown University and the Frederick National Laboratory for Cancer Research in Frederick, Maryland, aims to expand both institutions’ research and training missions in the biomedical sciences.
Category: GUMC Stories
-
New Immunotherapy Combination Tolerable, Effective in Patients with Advanced Kidney Cancer
A study led by Michael B. Atkins, MD, deputy director, Georgetown Lombardi Comprehensive Cancer Center, that combined an agent that blocks blood vessel formation with an immunotherapy agent was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney cancer who had not been previously treated.
Category: News Release
-
Unique Research Approach Finds FDA Approved Drug Shuts Down Ewing Sarcoma Cells in Lab
Based on a novel approach to drug discovery, researchers at Georgetown Lombardi Comprehensive Cancer Center say an agent approved to treat a type of leukemia might also help young people with a much rarer and aggressive form of cancer, Ewing sarcoma.
Category: News Release
-
Sharing Innovation and Motivation at the Ruesch Center Symposium
Nearly 300 medical professionals, patients, caregivers and advocates attended the 8th Annual Ruesch Center Symposium on December 1, listening to lectures on topics including precision medicine, immunotherapy, proton therapy and molecular imaging.
Category: GUMC Stories
-
New Test Provides Accurate Measure of DNA Damage from Chemical Compounds
A new biomarker test developed by researchers at Georgetown Lombardi Comprehensive Cancer Center and their colleagues can help predict, with up to 90 percent certainty, which chemical compounds can cause DNA damage that could lead to cancer.
Category: News Release
-
Schlegel Strives to Create Another Cervical Cancer Game Changer
While the HPV vaccine has been a game changer, recent research by Richard Schlegel, MD, PhD, may lead to another advance by treating women already infected with HPV and a precancerous condition that often leads to the development of cervical cancer.
Category: GUMC Stories
-
By Decoding How HPV Causes Cancer, Researchers Find a New Potential Treatment Strategy
A study that teases apart the biological mechanisms by which human papillomaviruses (HPV) cause cancer has found what researchers at Georgetown University Medical Center say is a new strategy that might provide targeted treatment for these cancers.
Category: News Release
-
Two Agents Deliver Knockout Punches to Ewing Sarcoma
When combined with an already FDA-approved chemotherapy, a novel agent developed by researchers at Georgetown University Medical Center appears to halt the ability of Ewing sarcoma to grow and progress.
Category: News Release